Press Releases
GNS Healthcare Chosen to Present Discovery of New Clinical Predictors of Overall Survival in Metastatic Colorectal Cancer at ESMO 2019 in Collaboration with the Alliance for Clinical Trials in Oncology
AI-driven in silico patients used to identify heterogeneous landscape of clinical predictors of overall survival in populations of patients with metastatic colorectal cancer. CAMBRIDGE, Mass.– [July 2, 2019] – GNS Healthcare (GNS), a leading precision medicine...
read moreScott Gottlieb to Keynote GNS Healthcare’s Precision Medicine Forum
23rd FDA Commissioner to share his thoughts on the convergence of data and AI in the development and use of new medicines along with industry luminaries from biopharma, payers, and patient foundations CAMBRIDGE, Mass., June 3, 2019 /PRNewswire/ -- GNS Healthcare...
read moreBusiness Health Care Group of Wisconsin Partners with GNS Healthcare to Improve Value of Care Across State
Innovative use of causal artificial intelligence to reveal the practices of medicine that drive improved health outcomes at lower costs MILWAUKEE and CAMBRIDGE, Mass., May 29, 2019 -- The Business Health Care Group (BHCG), a coalition of employers located...
read moreGNS Healthcare Presents Results of Metastatic Colorectal Cancer Collaboration with the Alliance for Clinical Trials in Oncology at ESMO 2018
Study identifies clinical and molecular drivers of survival at baseline to allow better risk stratification at initiation of treatment CAMBRIDGE, Mass.– [October 22, 2018] – GNS Healthcare (GNS), a leading precision medicine company, presented results in metastatic...
read moreGNS Healthcare Co-Founder and Chief Commercial Officer Iya Khalil Named to INC Magazine’s List of Top Female Founders for 2018
CAMBRIDGE, Mass.– October 5, 2018 – Each October, INC Magazine chooses leading women pioneers, entrepreneurs and innovators to profile in its annual Women Entrepreneurs issue. In their 2018 issue, GNS Co-Founder and Chief Commercial Officer Iya Khalil, PhD was...
read moreGNS Healthcare Names Healthcare Analytics Executive David Gascoigne as Chief Operating Officer
CAMBRIDGE, Mass.– October 3, 2018 – GNS Healthcare (GNS), a leading precision medicine company, has tapped data analytics veteran David Gascoigne as its Chief Operating Officer. Gascoigne has two decades of experience scaling and leading data analytics businesses in...
read moreClinical and Machine Learning Expert, Dr. Ziad Obermeyer Joins GNS Healthcare’s Strategic Advisory Board
CAMBRIDGE, Mass.– September 18, 2018 – GNS Healthcare (GNS), a leading precision medicine company, today announced the appointment of Ziad Obermeyer, MD, Associate Professor of Health Policy and Management at the UC Berkeley School of Public Health, to its strategic...
read moreCross-Industry Collaboration of GNS Healthcare, Amgen and Alliance for Clinical Trials in Oncology to Leverage AI to Advance Understanding of Treatment Response in Metastatic Colorectal Cancer
Collaboration to apply causal artificial intelligence and clinical trial data to identify factors that drive treatment response in patients with metastatic colorectal cancer
read moreGNS Healthcare Taps Technology Leader as CTO to Drive Productization of Causal AI Platform
CAMBRIDGE, Mass.– August 22, 2018 – GNS Healthcare (GNS), a leading precision medicine company, announced the hiring of veteran software executive Scott McKay as Chief Technology Officer. McKay brings over 25 years of hands-on experience in software development,...
read moreThe ALS Association Partners with GNS Healthcare to Apply AI to Accelerate Answer ALS Research
GNS Healthcare to combine its powerful, causal machine learning technology with the comprehensive Answer ALS patient datasets
read more